Why Is vTv Therapeutics Stock Trading Higher Today? - vTv Therapeutics (NASDAQ:VTVT)

vTv Therapeutics stock surge, fueled by a $51M private placement. Learn about their clinical-stage biopharmaceutical focus on cadisegliatin for type 1 diabetes. Stock up 111.8% at $18.

Related Keywords

Srinivas Akkaraju ,Rd Fund , ,Samsara Biocapital ,Managing General Partner ,